Episode

MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

Podcast
Run the List
Published
Jun 15, 2026
Duration seconds
1712
Processing state
not_requested
Canonical source
https://www.runthelistpodcast.com/
Audio
https://audio2.redcircle.com/episodes/7d20fc47-072a-4beb-b68b-49df54dc7059/stream.mp3
JSON
/v1/public/podcasts/run-the-list-675613/episodes/masld-metabolic-dysfunction-associated-steatotic-liver-disease
Markdown
/podcast/run-the-list-675613/masld-metabolic-dysfunction-associated-steatotic-liver-disease.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/run-the-list-675613/episodes/masld-metabolic-dysfunction-associated-steatotic-liver-disease/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/run-the-list-675613/masld-metabolic-dysfunction-associated-steatotic-liver-disease.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis. Advertising Inquiries: https://redcircle.com/brands